These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27607334)

  • 1. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis.
    Cordes F; Brückner M; Lenz P; Veltman K; Glauben R; Siegmund B; Hengst K; Schmidt MA; Cichon C; Bettenworth D
    Inflamm Bowel Dis; 2016 Oct; 22(10):2341-55. PubMed ID: 27607334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease.
    Zhao Y; Ma T; Chen W; Chen Y; Li M; Ren L; Chen J; Cao R; Feng Y; Zhang H; Shi R
    J Crohns Colitis; 2016 Jun; 10(6):703-12. PubMed ID: 26802080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
    Assa A; Vong L; Pinnell LJ; Rautava J; Avitzur N; Johnson-Henry KC; Sherman PM
    Inflamm Bowel Dis; 2015 Feb; 21(2):297-306. PubMed ID: 25590952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
    Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
    Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
    Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
    J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.
    Huang Z; Shi T; Zhou Q; Shi S; Zhao R; Shi H; Dong L; Zhang C; Zeng K; Chen J; Zhang J
    Gut; 2014 Aug; 63(8):1247-57. PubMed ID: 24000293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
    Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
    Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated virus carrying thymosin β
    Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
    World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair.
    Lopetuso LR; De Salvo C; Pastorelli L; Rana N; Senkfor HN; Petito V; Di Martino L; Scaldaferri F; Gasbarrini A; Cominelli F; Abbott DW; Goodman WA; Pizarro TT
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9362-E9370. PubMed ID: 30224451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis.
    Nighot P; Young K; Nighot M; Rawat M; Sung EJ; Maharshak N; Plevy SE; Ma T; Blikslager A
    Inflamm Bowel Dis; 2013 Dec; 19(13):2867-77. PubMed ID: 24030525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10/microRNA-155/SHIP-1 signaling pathway is crucial for commensal bacteria induced spontaneous colitis.
    Li Y; Tian Y; Zhu W; Gong J; Guo Z; Guo F; Gu L; Li J
    Biochem Pharmacol; 2016 Sep; 116():100-6. PubMed ID: 27395764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.
    Wei SC; Yang-Yen HF; Tsao PN; Weng MT; Tung CC; Yu LCH; Lai LC; Hsiao JH; Chuang EY; Shun CT; Ni YH; Xavier RJ; Podolsky DK; Yen JJY; Wong JM
    Inflamm Bowel Dis; 2017 Oct; 23(10):1730-1740. PubMed ID: 28906292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of microRNA-10b promotes DSS-induced inflammatory response via impairing intestinal barrier function.
    Zhao K; Wang C; Liu Y; Li Y; Hui T; Wang G; Zhang X; Xue X; Kang J; Feng G
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):48-54. PubMed ID: 36343490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.